Hematopoiesis in MBL and CLL Versus Healthy Age-Matched Control Subjects
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age40+
SponsorMayo Clinic
About this trial
This study evaluates hematopoiesis to determine how MBL/CLL affected bone marrow responds to fight off infections in the body.
Eligibility criteria
Qualifiers
Subjects in the CLL cohort who are eligible for these studies will have a clinically established diagnosis of CLL as assessed by flow cytometry and will include subjects who
Remain untreated
Are currently being treated
Who have already been treated
Disqualifiers
Anyone under 40
Healthy control subjects must not have a diagnosis of CLL or MBL
Trial design
Treatments tested in this trial
- Non-Interventional Study
Treatment groups
50 Participants
are divided into 1 treatment groupLocations
1Mayo Clinic in Rochester55905, RochesterMinnesota, United States
Sponsors and collaborators
Mayo Clinic
Lead sponsor
Source ClinicalTrials.gov